Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1243.80
-26.00 (-2.05%) Dr Reddys Laboratories informs about press release
Date: 08-02-2016Dr Reddys Laboratories has informed about a press release dated February 08, 2016 titled ‘Promius Pharma? Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%’.
The above information is a part of company’s filings submitted to BSE.